Not patches
High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+/regulatory T-cell infiltration
According to standard scholarly practice, it is recommended to provide appropriate citation and attribution whenever technically possible
Genitourinary Common (1% to 10%): Urinary tract infection, urolithiasis Postmarketing reports : Urolithiasis Hepatic Common (1% to 10%): Cholelithiasis, cholecystitis Uncommon (0.1% to 1%): Increased bilirubin Postmarketing reports : Cholecystitis, cholelithiasis requiring cholecystectomy Hypersensitivity Uncommon (0.1% to 1%): Hypersensitivity Rare (0.01% to 0.1%): Anaphylactic reaction Frequency not reported : Allergic reactions Postmarketing reports : Hypersensitivity, anaphylaxis Hypersensitivity included related adverse events such as rash and urticaria
Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, et al
